Log in
NASDAQ:XRAY

DENTSPLY SIRONA Stock Forecast, Price & News

$47.72
+0.33 (+0.70 %)
(As of 09/17/2020 12:00 AM ET)
Add
Compare
Today's Range
$46.26
Now: $47.72
$47.90
50-Day Range
$42.00
MA: $44.62
$47.39
52-Week Range
$31.58
Now: $47.72
$60.87
Volume1.55 million shs
Average Volume2.08 million shs
Market Capitalization$10.43 billion
P/E RatioN/A
Dividend Yield0.84%
Beta0.99
DENTSPLY SIRONA Inc. designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. The company also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials. In addition, it provides dental technology products, including dental implants and related scanning equipment, treatment software, and orthodontic appliances for dental practitioners and specialist, and dental laboratories; and dental equipment, such as treatment centers, imaging equipment, and computer aided design and machining systems for dental practitioners and laboratories. Further, the company offers healthcare consumable products, such as urology catheters, medical drills, and other non-medical products. It markets and sells dental products through distributors, dealers, and importers to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools; and urology products directly to patients, as well as through distributors to urologists, urology nurses, and general practitioners. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in York, Pennsylvania.
Read More
DENTSPLY SIRONA logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.3Community Rank: 2.4Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.64 out of 5 stars


Industry, Sector and Symbol

Industry Dental equipment & supplies
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:XRAY
CUSIP24903010
Phone844-546-3722

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.03 billion
Cash Flow$4.25 per share
Book Value$22.91 per share

Profitability

Net Income$262.90 million

Miscellaneous

Employees15,200
Market Cap$10.43 billion
Next Earnings Date11/5/2020 (Estimated)
OptionableOptionable
$47.72
+0.33 (+0.70 %)
(As of 09/17/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive XRAY News and Ratings via Email

Sign-up to receive the latest news and ratings for XRAY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











DENTSPLY SIRONA (NASDAQ:XRAY) Frequently Asked Questions

How has DENTSPLY SIRONA's stock price been impacted by Coronavirus (COVID-19)?

DENTSPLY SIRONA's stock was trading at $42.56 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, XRAY stock has increased by 12.1% and is now trading at $47.72.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of DENTSPLY SIRONA?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DENTSPLY SIRONA in the last year. There are currently 7 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for DENTSPLY SIRONA
.

When is DENTSPLY SIRONA's next earnings date?

DENTSPLY SIRONA is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for DENTSPLY SIRONA
.

How were DENTSPLY SIRONA's earnings last quarter?

DENTSPLY SIRONA Inc (NASDAQ:XRAY) issued its quarterly earnings results on Thursday, August, 6th. The medical instruments supplier reported ($0.18) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.02) by $0.16. The medical instruments supplier had revenue of $490.60 million for the quarter, compared to analysts' expectations of $492.55 million. DENTSPLY SIRONA had a negative net margin of 1.40% and a positive return on equity of 7.13%. The company's revenue for the quarter was down 51.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.66 EPS.
View DENTSPLY SIRONA's earnings history
.

How often does DENTSPLY SIRONA pay dividends? What is the dividend yield for DENTSPLY SIRONA?

DENTSPLY SIRONA declared a quarterly dividend on Wednesday, July 29th. Investors of record on Friday, September 25th will be given a dividend of $0.10 per share on Friday, October 9th. This represents a $0.40 dividend on an annualized basis and a dividend yield of 0.84%. The ex-dividend date of this dividend is Thursday, September 24th.
View DENTSPLY SIRONA's dividend history
.

What price target have analysts set for XRAY?

14 brokerages have issued 1 year price targets for DENTSPLY SIRONA's stock. Their forecasts range from $38.00 to $66.00. On average, they expect DENTSPLY SIRONA's stock price to reach $49.29 in the next twelve months. This suggests a possible upside of 3.3% from the stock's current price.
View analysts' price targets for DENTSPLY SIRONA
.

Are investors shorting DENTSPLY SIRONA?

DENTSPLY SIRONA saw a drop in short interest in August. As of August 31st, there was short interest totaling 4,660,000 shares, a drop of 17.8% from the August 15th total of 5,670,000 shares. Based on an average daily trading volume, of 1,660,000 shares, the short-interest ratio is currently 2.8 days. Approximately 2.1% of the company's stock are short sold.
View DENTSPLY SIRONA's Short Interest
.

Who are some of DENTSPLY SIRONA's key competitors?

What other stocks do shareholders of DENTSPLY SIRONA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other DENTSPLY SIRONA investors own include NVIDIA (NVDA), Intel (INTC), QUALCOMM (QCOM), Boeing (BA), General Electric (GE), IBM (IBM), Gilead Sciences (GILD), Broadcom (AVGO), Comcast (CMCSA) and Netflix (NFLX).

Who are DENTSPLY SIRONA's key executives?

DENTSPLY SIRONA's management team includes the following people:
  • Mr. Nicholas William Alexos, Exec. VP & CFO (Age 55)
  • Mr. Keith John Ebling, EVP, Gen. Counsel & Sec. (Age 50)
  • Ms. Maureen J. MacInnis, Sr. VP, Chief HR Officer & Communications (Age 58)
  • Mr. Donald M. Casey Jr., CEO & Director (Age 59)
  • Mr. Dominique P. Legros, Sr. VP of Equipment, Technologies & Healthcare Segment (Age 59)

What is DENTSPLY SIRONA's stock symbol?

DENTSPLY SIRONA trades on the NASDAQ under the ticker symbol "XRAY."

Who are DENTSPLY SIRONA's major shareholders?

DENTSPLY SIRONA's stock is owned by a variety of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (11.49%), First Eagle Investment Management LLC (3.21%), Nuance Investments LLC (3.06%), Bank of Montreal Can (0.94%), Ninety One UK Ltd (0.89%) and New York State Common Retirement Fund (0.88%). Company insiders that own DENTSPLY SIRONA stock include Betsy D Holden, Daniel P Key, Donald M Jr Casey, Eric Brandt, Gregory T Lucier, Markus Boehringer, Maureen J Macinnis, Michael C Alfano, Michael J Coleman and William E Newell.
View institutional ownership trends for DENTSPLY SIRONA
.

Which major investors are selling DENTSPLY SIRONA stock?

XRAY stock was sold by a variety of institutional investors in the last quarter, including Prudential Financial Inc., Vanguard Group Inc., FMR LLC, FMR LLC, SG Americas Securities LLC, Candriam Luxembourg S.C.A., Robeco Institutional Asset Management B.V., and State of Wisconsin Investment Board. Company insiders that have sold DENTSPLY SIRONA company stock in the last year include Michael C Alfano, and William E Newell.
View insider buying and selling activity for DENTSPLY SIRONA
.

Which major investors are buying DENTSPLY SIRONA stock?

XRAY stock was purchased by a variety of institutional investors in the last quarter, including Ninety One UK Ltd, Sound Shore Management Inc CT, Nuance Investments LLC, Bank of Montreal Can, Victory Capital Management Inc., Sumitomo Mitsui Trust Holdings Inc., State of Tennessee Treasury Department, and Reinhart Partners Inc.. Company insiders that have bought DENTSPLY SIRONA stock in the last two years include Betsy D Holden, Daniel P Key, Donald M Jr Casey, and Gregory T Lucier.
View insider buying and selling activity for DENTSPLY SIRONA
.

How do I buy shares of DENTSPLY SIRONA?

Shares of XRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is DENTSPLY SIRONA's stock price today?

One share of XRAY stock can currently be purchased for approximately $47.72.

How big of a company is DENTSPLY SIRONA?

DENTSPLY SIRONA has a market capitalization of $10.43 billion and generates $4.03 billion in revenue each year. The medical instruments supplier earns $262.90 million in net income (profit) each year or $2.45 on an earnings per share basis. DENTSPLY SIRONA employs 15,200 workers across the globe.

What is DENTSPLY SIRONA's official website?

The official website for DENTSPLY SIRONA is www.dentsplysirona.com.

How can I contact DENTSPLY SIRONA?

DENTSPLY SIRONA's mailing address is 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC, 28277. The medical instruments supplier can be reached via phone at 844-546-3722 or via email at [email protected]

This page was last updated on 9/18/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.